However, tumor growth inhibition was better when FoxM1-shRNA was combined with IR (FoxM1-shRNA+IR: T/C%=30.5%; vs. NC p=0.00038; vs. FoxM1-shRNA p=0.020; vs. NC+IR p= 0.017) (Figure 5C). The gene discussed is FOXM1; the disease is neoplasm.